Third evaluation within the FINOSE collaboration

12 May 2020 - Together with the corresponding authorities in Finland and Norway, TLV has produced a joint evaluation report ...

Read more →

Health economic assessment of gene therapy Zynteglo in transfusion-dependent beta-thalassemia

11 May 2020 - TLV has developed a health-economic knowledge base for the Zynteglo gene therapy (autologous CD34-positive cells expressing the ...

Read more →

Health economic assessment of Luxturna in the treatment of visual impairment caused by hereditary eye disease

29 May 2019 - TLV has produced a health economic knowledge base for the region for the drug Luxturna (voretigene ...

Read more →

Health economic assessment of Tegsedi in hereditary transthyretin amyloidosis

17 May 2019 - TLV has produced a health economic knowledge base for the regions for Tegsedi (inotersen) that treat hereditary ...

Read more →